Creon 25000 Capsules

Creon is a global pharmaceutical brand specifically formulated for Pancreatic Enzyme Replacement Therapy (PERT). It contains pancreatin, a mixture of digestive enzymes (lipase, protease, and amylase) used to help people with pancreatic insufficiency digest food correctly. The brand's history is deeply rooted in German pharmaceutical innovation, originally developed by Solvay Pharmaceuticals, a Belgian company with major operations in Hannover, Germany.

Over the last decade, the ownership of Creon has undergone significant changes due to major industry mergers. The brand transitioned from Solvay to Abbott Laboratories and then to Mylan. Following the 2020 merger between Mylan and Pfizer's Upjohn division, the brand now falls under the umbrella of Viatris Inc., a global healthcare company. Creon remains one of the most widely prescribed enzyme supplements worldwide, known for its specific enteric-coated microsphere technology designed to survive stomach acid and release effectively in the small intestine.